- Home
- IMNN vs DHAI Comparison
IMNN vs DHAI Comparison
Compare IMNN & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- DHAI
- Stock Information
- Founded
- IMNN 1982
- DHAI 2007
- Country
- IMNN United States
- DHAI United States
- Employees
- IMNN N/A
- DHAI N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- DHAI
- Sector
- IMNN Health Care
- DHAI
- Exchange
- IMNN Nasdaq
- DHAI NYSE
- Market Cap
- IMNN 12.1M
- DHAI 10.5M
- IPO Year
- IMNN 1985
- DHAI N/A
- Fundamental
- Price
- IMNN $0.77
- DHAI $0.24
- Analyst Decision
- IMNN Buy
- DHAI
- Analyst Count
- IMNN 2
- DHAI 0
- Target Price
- IMNN $14.00
- DHAI N/A
- AVG Volume (30 Days)
- IMNN 2.3M
- DHAI 6.3M
- Earning Date
- IMNN 08-13-2025
- DHAI 08-18-2025
- Dividend Yield
- IMNN N/A
- DHAI N/A
- EPS Growth
- IMNN N/A
- DHAI N/A
- EPS
- IMNN N/A
- DHAI N/A
- Revenue
- IMNN N/A
- DHAI $69,573,000.00
- Revenue This Year
- IMNN N/A
- DHAI N/A
- Revenue Next Year
- IMNN N/A
- DHAI N/A
- P/E Ratio
- IMNN N/A
- DHAI N/A
- Revenue Growth
- IMNN N/A
- DHAI 5.40
- 52 Week Low
- IMNN $0.37
- DHAI $0.12
- 52 Week High
- IMNN $3.65
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- IMNN 40.86
- DHAI 54.46
- Support Level
- IMNN $0.70
- DHAI $0.24
- Resistance Level
- IMNN $0.86
- DHAI $0.27
- Average True Range (ATR)
- IMNN 0.10
- DHAI 0.04
- MACD
- IMNN -0.05
- DHAI 0.00
- Stochastic Oscillator
- IMNN 10.34
- DHAI 41.07
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.